Adial Pharmaceuticals Inc (NASDAQ: ADIL) has announced data in a preclinical model of pain reduction. Based on the data, Adial's subsidiary Purnovate Inc selected PNV-5030 as the lead compound for its ...
With the business potentially at an important milestone, we thought we'd take a closer look at PolyNovo Limited's (ASX:PNV) future prospects. PolyNovo Limited develops medical devices in the United ...
The Price section compares costs of the same generic drugs across brands and is purely for information purpose. Medindia neither buys nor sells drugs. Meclizine (PNV) is an antihistamine, prescribed ...
Fintel reports that on August 5, 2024, BELL POTTER SECURITIES downgraded their outlook for PolyNovo (ASX:PNV) from Buy to Hold. As of August 6, 2024, the average one-year price target for PolyNovo is ...
The average one-year price target for PolyNovo (ASX:PNV) has been revised to 1.80 / share. This is an decrease of 12.02% from the prior estimate of 2.05 dated November 26, 2023. The price target is an ...
At close: 27 February at 4:10:30 pm AEDT ...
PolyNovo Limited (ASX:PNV), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the ASX over the last few months. Shareholders may appreciate the ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results